Answers are grounded in this paper and cite their sources.
In our study, we found that whole-genome sequencing provided rapid and accurate genomic profiling in patients with AML or MDS. Such sequencing also provided a greater diagnostic yield than conventional cytogenetic analysis and more efficient risk stratification on the basis of standard risk categories. (Funded by the Siteman Cancer Research Fund and others.).
No takes yet. Share an insight, caveat, or question.
Duncavage et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: